TWO new regimens for treating ulcers caused by H. pylori

September 1996

The FDA just approved TWO new regimens for treating ulcers caused by H. pylori.

One is Glaxo's new Tritec plus Biaxin (clarithromycin).

Tritec is a combination of ranitidine (Zantac) and bismuth. The ranitidine suppresses acid...bismuth helps suppress H. pylori.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote